Zobrazeno 1 - 10
of 177
pro vyhledávání: '"Lode J. Swinnen"'
Autor:
Philip H. Imus, Hua-Ling Tsai, Leo Luznik, Ephraim J. Fuchs, Carol Ann Huff, Douglas E. Gladstone, Patrick Lowery, Richard F. Ambinder, Ivan M. Borrello, Lode J. Swinnen, Nina Wagner-Johnston, Christian B. Gocke, Syed Abbas Ali, F.Javier Bolaños-Meade, Ravi Varadhan, Richard J. Jones
Publikováno v:
Blood Advances, Vol 3, Iss 17, Pp 2608-2616 (2019)
Abstract: Hematologic malignancies in older people are unlikely to be cured with chemotherapy alone. Advances in allogeneic blood or marrow transplantation (alloBMT), especially nonmyeloablative (NMA) conditioning and the use of haploidentical donors
Externí odkaz:
https://doaj.org/article/197de5e065234acea249f8b75efa3cfa
Autor:
Yvette L. Kasamon, Richard F. Ambinder, Ephraim J. Fuchs, Marianna Zahurak, Gary L. Rosner, Javier Bolaños-Meade, Mark J. Levis, Douglas E. Gladstone, Carol Ann Huff, Lode J. Swinnen, William H. Matsui, Ivan Borrello, Robert A. Brodsky, Richard J. Jones, Leo Luznik
Publikováno v:
Blood Advances, Vol 1, Iss 4, Pp 288-292 (2017)
Abstract: Allogeneic blood or marrow transplantation (BMT) candidates may lack HLA-matched, related haploidentical, and unrelated umbilical cord options. Barriers to partially HLA-mismatched, unrelated donor (mMUD) BMT include excess graft-versus-hos
Externí odkaz:
https://doaj.org/article/af2ec2c8d00b48949c2586a19a5e7f02
Autor:
Shannon R. McCurdy, Yvette L. Kasamon, Christopher G. Kanakry, Javier Bolaños-Meade, Hua-Ling Tsai, Margaret M. Showel, Jennifer A. Kanakry, Heather J. Symons, Ivana Gojo, B. Douglas Smith, Maria P. Bettinotti, William H. Matsui, Amy E. Dezern, Carol Ann Huff, Ivan Borrello, Keith W. Pratz, Douglas E. Gladstone, Lode J. Swinnen, Robert A. Brodsky, Mark J. Levis, Richard F. Ambinder, Ephraim J. Fuchs, Gary L. Rosner, Richard J. Jones, Leo Luznik
Publikováno v:
Haematologica, Vol 102, Iss 2 (2017)
Composite endpoints that not only encompass mortality and relapse, but other critical post-transplant events such as graft-versus-host disease, are being increasingly utilized to quantify survival without significant morbidity after allogeneic blood
Externí odkaz:
https://doaj.org/article/6772e489f3ba456aaf2f50f5512d6f5d
Autor:
Craig Horbinski, Louis Burt Nabors, Jana Portnow, Joachim Baehring, Ankush Bhatia, Orin Bloch, Steven Brem, Nicholas Butowski, Donald M. Cannon, Samuel Chao, Milan G. Chheda, Andrew J. Fabiano, Peter Forsyth, Pierre Gigilio, Jona Hattangadi-Gluth, Matthias Holdhoff, Larry Junck, Thomas Kaley, Ryan Merrell, Maciej M. Mrugala, Seema Nagpal, Lucien A. Nedzi, Kathryn Nevel, Phioanh L. Nghiemphu, Ian Parney, Toral R. Patel, Katherine Peters, Vinay K. Puduvalli, Jason Rockhill, Chad Rusthoven, Nicole Shonka, Lode J. Swinnen, Stephanie Weiss, Patrick Yung Wen, Nicole E. Willmarth, Mary Anne Bergman, Susan Darlow
Publikováno v:
Journal of the National Comprehensive Cancer Network. 21:12-20
The NCCN Guidelines for Central Nervous System (CNS) Cancers focus on management of the following adult CNS cancers: glioma (WHO grade 1, WHO grade 2–3 oligodendroglioma [1p19q codeleted, IDH-mutant], WHO grade 2–4 IDH-mutant astrocytoma, WHO gra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c8b8bc460cc4c58d4e2c4befdad44d52
https://doi.org/10.6004/jnccn.2023.0002
https://doi.org/10.6004/jnccn.2023.0002
Autor:
Amy DeZern, Marianna L Zahurak, Heather J Symons, Kenneth R. Cooke, Carol Ann Huff, Tania Jain, Lode J Swinnen, Philip Hollingsworth Imus, Nina D. Wagner-Johnston, Richard F Ambinder, Mark J. Levis, Leo Luznik, Javier Bolaños-Meade, Ephraim J Fuchs, Richard J Jones, Robert A. Brodsky
Publikováno v:
Blood Journal.
Severe aplastic anemia (SAA) is a marrow failure disorder with high morbidity and mortality. It is treated with bone marrow transplantation (BMT) for those with fully matched donors or immunosuppressive therapy (IST) for those who lack such a donor,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d9e3d009596123a752e657d28ec5cc43
https://doi.org/10.1182/blood.2023020435
https://doi.org/10.1182/blood.2023020435
Autor:
Jonathan Allen Webster, Madison C. Reed, Hua-Ling Tsai, Alexander J. Ambinder, Tania Jain, Amy E. DeZern, Mark J. Levis, Margaret M. Showel, Gabrielle T. Prince, Christopher S. Hourigan, Javier Bolaños-Meade, Lukasz P. Gondek, Gabriel Ghiaur, William Brian Dalton, Suman Paul, Ephraim J. Fuchs, Christian B. Gocke, Abbas Abbas Ali, Douglas E. Gladstone, Carol Ann Huff, Ivan M. Borrello, Lode J. Swinnen, Nina D. Wagner-Johnston, Richard F. Ambinder, Leo Luznik, Ivana Gojo, B. Douglas Douglas Smith, Ravi Varadhan, Richard J. Jones, Philip H. Imus
Publikováno v:
Blood. 140:4813-4815
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ab4a56b16b86015e1b06eb3179b406d7
https://doi.org/10.1182/blood-2022-171038
https://doi.org/10.1182/blood-2022-171038
Autor:
Amy E. DeZern, Alexander J. Ambinder, Matthew D. Smith, Carol Ann Huff, Christian B. Gocke, Douglas E. Gladstone, Gabriel Ghiaur, William Dalton, Philip H. Imus, Mark J. Levis, Lukasz P. Gondek, Jonathan Webster, Ivana Gojo, Gabrielle T. Prince, Tania Jain, Margaret M. Showel, Ivan Borrello, Ravi Varadhan, Javier Bolaños-Meade, Hua-Ling Tsai, B. Douglas Smith, Nina Wagner-Johnston, Leo Luznik, Syed Abbas Ali, Richard Jones, Richard F. Ambinder, Ephraim J. Fuchs, Lode J. Swinnen
Publikováno v:
Clin Lymphoma Myeloma Leuk
Introduction Mutations in the IDH1 or IDH2 genes are detected in approximately 20% of cases of acute myeloid leukemia (AML). Few studies have examined the impact of IDH mutations in AML on allogeneic bone marrow transplant (alloBMT) outcomes. Patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0215195cbf6b25e9d8a024fa569e52ce
https://doi.org/10.1016/j.clml.2021.09.022
https://doi.org/10.1016/j.clml.2021.09.022
Autor:
L. Elizabeth Budde, Rachel Rabinovitch, Beth Christian, Paolo Caimi, Joseph Tuscano, Jakub Svoboda, Thomas M. Habermann, Ann S. LaCasce, Martha Glenn, Andrew D. Zelenetz, Jeremy S. Abramson, Nadia Khan, Megan S. Lim, Bita Fakhri, Nancy L. Bartlett, Praveen Ramakrishnan, Julie E. Chang, Kenneth B. Roberts, Sven de Vos, Leo I. Gordon, Stephen D. Smith, Erin Reid, Julie M. Vose, Mayur Narkhede, Ranjana H. Advani, Mary A. Dwyer, Bhagirathbhai Dholaria, Boyu Hu, Eric D. Hsi, Hayder Saeed, Hema Sundar, Lode J. Swinnen, Chris R. Kelsey, Luis Fayad, Susan Krivacic, Mark S. Kaminski, Francisco J. Hernandez-Ilizaliturri
Publikováno v:
Journal of the National Comprehensive Cancer Network. 19:1218-1230
In the last decade, a better understanding of the molecular pathogenesis of B-cell non-Hodgkin lymphomas has resulted in the development of novel targeted therapies, such as small molecule inhibitors of select kinases in the B-cell receptor pathway,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e98ec29021b5c288663888dceaa1d45f
https://doi.org/10.6004/jnccn.2021.0054
https://doi.org/10.6004/jnccn.2021.0054
Autor:
Michael S. Hughes, Cole H. Sterling, Ravi Varadhan, Richard F. Ambinder, Richard J. Jones, Ronald J. Sweren, Sima Rozati, Javier Bolaños-Meade, Leo Luznik, Philip H. Imus, Syed Abbas Ali, Ivan M. Borrello, Carol Ann Huff, T. Jain, Alexander Ambinder, Amy E. DeZern, Christian B. Gocke, Douglas E. Gladstone, Lode J. Swinnen, Nina D. Wagner-Johnston, Ephraim J. Fuchs
Publikováno v:
Leukemialymphoma. 63(12)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db42715594ae2636502f5e79caf56405
https://pubmed.ncbi.nlm.nih.gov/35915978
https://pubmed.ncbi.nlm.nih.gov/35915978
Autor:
Cole H. Sterling, Michael S. Hughes, Hua-Ling Tsai, Kathryn Yarkony, Ephraim J. Fuchs, Lode J. Swinnen, Suman Paul, Javier Bolaños-Meade, Leo Luznik, Philip H. Imus, Syed Abbas Ali, Tania Jain, Alexander Ambinder, Amy DeZern, Carol Ann Huff, Christian B. Gocke, Ravi Varadhan, Nina Wagner-Johnston, Richard J. Jones, Richard F. Ambinder
Publikováno v:
Transplantation and Cellular Therapy. 29:267.e1-267.e5
The use of post-transplantation cyclophosphamide (PTCy) for graft-versus host-disease (GVHD) prophylaxis has revolutionized allogeneic blood or marrow transplantation (alloBMT), but there is limited published experience in peripheral T-cell lymphoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::711043a700b1b739d22e3f36527ff4ed
https://doi.org/10.1016/j.jtct.2022.12.009
https://doi.org/10.1016/j.jtct.2022.12.009